AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Scientists studying an aggressive cancer that affects thousands of dogs annually have uncovered a genetic signature that ...

Whether or not to cover these procedures, and if so, coverage details, should be decided on before their popularity grows.

Asiawu Imam says the therapy will make a huge difference A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England.

A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England. About 50 people a year with the inherited blood disorder are likely ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells and engineering them to recognize specific targets ...

One of the world’s most expensive medicines will be used to treat some patients with sickle cell disease in England using the state-funded National Health Service.Most Read from BloombergHow the 2025 ...